These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7994822)

  • 1. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.
    London GM; Pannier B; Guerin AP; Marchais SJ; Safar ME; Cuche JL
    Circulation; 1994 Dec; 90(6):2786-96. PubMed ID: 7994822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac hypertrophy and arterial compliance after antihypertensive treatment].
    Asmar RG; Pannier BM; London GM; Safar ME
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():79-83. PubMed ID: 1838923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals.
    Benetos A; Cambien F; Gautier S; Ricard S; Safar M; Laurent S; Lacolley P; Poirier O; Topouchian J; Asmar R
    Hypertension; 1996 Dec; 28(6):1081-4. PubMed ID: 8952600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.
    London GM; Pannier B; Vicaut E; Guérin AP; Marchais SJ; Safar ME; Cuche JL
    J Hypertens; 1996 Sep; 14(9):1139-46. PubMed ID: 8986916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.
    Pannier BM; Guerin AP; Marchais SJ; London GM
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1074-7. PubMed ID: 11903319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension.
    Asmar RG; Pannier B; Santoni JP; Laurent S; London GM; Levy BI; Safar ME
    Circulation; 1988 Oct; 78(4):941-50. PubMed ID: 2971473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac hypertrophy and arterial compliance following drug treatment in hypertension.
    Asmar RG; Pannier BM; London GM; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S37-9. PubMed ID: 1725199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure and left ventricular changes during antihypertensive treatment: perindopril versus isradipine.
    Grandi AM; Bignotti M; Gaudio G; Zanzi P; Guasti L; Venco A
    J Cardiovasc Pharmacol; 1995 Nov; 26(5):737-41. PubMed ID: 8637188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
    Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
    Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
    Ahimastos AA; Aggarwal A; D'Orsa KM; Formosa MF; White AJ; Savarirayan R; Dart AM; Kingwell BA
    JAMA; 2007 Oct; 298(13):1539-47. PubMed ID: 17911499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimization of BP Control and Arterial Elasticity With Fixed Combination Therapy Perindopril and Amlodipine In Patients With Arterial Hypertension and Increased Pulse Wave Velocity].
    Nedogoda SV; Konradi AO; Zvartau NE; Chumachek EV; Ledyaeva AA; Tsoma VV; Salasyuk AS; Judina JS; Smirnova VO; Khripaeva VJ; Palashkin RV
    Kardiologiia; 2017 Mar; 57(3):31-38. PubMed ID: 28762933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients.
    Sennesael JJ; Lamote JG; Violet I; Tasse S; Verbeelen DL
    Am J Kidney Dis; 1996 May; 27(5):701-8. PubMed ID: 8629631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension.
    Anan F; Takahashi N; Ooie T; Yufu K; Hara M; Nakagawa M; Yonemochi H; Saikawa T; Yoshimatsu H
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):353-9. PubMed ID: 15918057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients.
    Girerd X; Giannattasio C; Moulin C; Safar M; Mancia G; Laurent S
    J Am Coll Cardiol; 1998 Apr; 31(5):1064-73. PubMed ID: 9562008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
    Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T
    Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the effect of hemodialysis on peripheral and central arterial pressure waveforms.
    Covic A; Goldsmith DJ; Panaghiu L; Covic M; Sedor J
    Kidney Int; 2000 Jun; 57(6):2634-43. PubMed ID: 10844634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
    Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM; Schaefer A
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.